HEADER TRANSFERASE/TRANSFERASE INHIBITOR 04-JUN-10 3NC4 TITLE THE BINDING OF BETA-D-GLUCOPYRANOSYL-THIOSEMICARBAZONE DERIVATIVES TO TITLE 2 GLYCOGEN PHOSPHORYLASE: A NEW CLASS OF INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOGEN PHOSPHORYLASE, MUSCLE FORM; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MYOPHOSPHORYLASE; COMPND 5 EC: 2.4.1.1 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ORYCTOLAGUS CUNICULUS; SOURCE 3 ORGANISM_COMMON: EUROPEAN RABBIT,JAPANESE WHITE RABBIT,DOMESTIC SOURCE 4 RABBIT,RABBITS; SOURCE 5 ORGANISM_TAXID: 9986; SOURCE 6 STRAIN: RABBIT; SOURCE 7 OTHER_DETAILS: MUSCLE KEYWDS GLYCOGENOLYSIS, TYPE 2 DIABETES, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.-M.ALEXACOU REVDAT 5 22-NOV-23 3NC4 1 REMARK REVDAT 4 06-SEP-23 3NC4 1 HETSYN REVDAT 3 29-JUL-20 3NC4 1 REMARK SITE REVDAT 2 17-JUL-19 3NC4 1 REMARK LINK REVDAT 1 05-JAN-11 3NC4 0 JRNL AUTH K.M.ALEXACOU,A.C.TENCHIU DELEANU,E.D.CHRYSINA,M.D.CHARAVGI, JRNL AUTH 2 I.D.KOSTAS,S.E.ZOGRAPHOS,N.G.OIKONOMAKOS,D.D.LEONIDAS JRNL TITL THE BINDING OF BETA-D-GLUCOPYRANOSYL-THIOSEMICARBAZONE JRNL TITL 2 DERIVATIVES TO GLYCOGEN PHOSPHORYLASE: A NEW CLASS OF JRNL TITL 3 INHIBITORS JRNL REF BIOORG.MED.CHEM. V. 18 7911 2010 JRNL REFN ISSN 0968-0896 JRNL PMID 20947361 JRNL DOI 10.1016/J.BMC.2010.09.039 REMARK 2 REMARK 2 RESOLUTION. 2.07 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.3.0037 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.07 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 80.4 REMARK 3 NUMBER OF REFLECTIONS : 45659 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2431 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.07 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.12 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3320 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 81.37 REMARK 3 BIN R VALUE (WORKING SET) : 0.2170 REMARK 3 BIN FREE R VALUE SET COUNT : 187 REMARK 3 BIN FREE R VALUE : 0.2940 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6604 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 282 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.64 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : -0.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.253 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.194 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.113 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.109 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.942 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6815 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 9228 ; 1.152 ; 1.960 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 809 ; 5.527 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 348 ;34.992 ;23.534 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1178 ;16.267 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 59 ;20.554 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 998 ; 0.083 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5231 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 3026 ; 0.194 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 4619 ; 0.306 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 375 ; 0.140 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 37 ; 0.207 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 7 ; 0.150 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4165 ; 0.651 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 6524 ; 1.116 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3034 ; 1.610 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2704 ; 2.543 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3NC4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-JUN-10. REMARK 100 THE DEPOSITION ID IS D_1000059643. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 6.7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X13 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.815 REMARK 200 MONOCHROMATOR : CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48018 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.070 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 80.4 REMARK 200 DATA REDUNDANCY : 2.500 REMARK 200 R MERGE (I) : 0.08400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.5900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.07 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 83.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.43500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.720 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 2PRJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.45 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS GROWN FROM 20 MG/ML OF REMARK 280 PROTEIN IN A BUFFER SOLUTION CONTAINING 10 MM BES PH 6.7, 1 MM REMARK 280 EDTA, 3 MM DTT. CRYSTALS WERE SOAKED WITH 20MM INHIBITOR IN 20% REMARK 280 DMSO FOR 21 HRS 10 MINS, PH 6.7, SMALL TUBES, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.92150 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 64.25850 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 64.25850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 86.88225 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 64.25850 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 64.25850 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 28.96075 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 64.25850 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 64.25850 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 86.88225 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 64.25850 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 64.25850 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 28.96075 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 57.92150 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4720 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 56000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 115.84300 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 2 REMARK 465 PRO A 3 REMARK 465 LEU A 4 REMARK 465 SER A 5 REMARK 465 ASP A 6 REMARK 465 GLN A 7 REMARK 465 GLU A 8 REMARK 465 LYS A 9 REMARK 465 ARG A 10 REMARK 465 LYS A 11 REMARK 465 LYS A 255 REMARK 465 ASP A 256 REMARK 465 PHE A 257 REMARK 465 ASN A 258 REMARK 465 VAL A 259 REMARK 465 GLY A 260 REMARK 465 LYS A 315 REMARK 465 PHE A 316 REMARK 465 GLY A 317 REMARK 465 CYS A 318 REMARK 465 ARG A 319 REMARK 465 ASP A 320 REMARK 465 PRO A 321 REMARK 465 VAL A 322 REMARK 465 ARG A 323 REMARK 465 PRO A 837 REMARK 465 ASP A 838 REMARK 465 GLU A 839 REMARK 465 LYS A 840 REMARK 465 ILE A 841 REMARK 465 PRO A 842 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 19 64.78 -111.68 REMARK 500 LEU A 131 35.64 -91.58 REMARK 500 TYR A 203 -133.67 66.03 REMARK 500 ASP A 283 -69.72 82.82 REMARK 500 PHE A 285 -177.51 -62.49 REMARK 500 ASP A 339 -164.23 63.14 REMARK 500 THR A 466 -81.33 -127.42 REMARK 500 LEU A 492 -62.61 -138.46 REMARK 500 ASP A 514 73.83 -156.48 REMARK 500 ARG A 551 -71.09 -57.36 REMARK 500 LYS A 568 163.33 166.06 REMARK 500 SER A 674 -56.88 -133.92 REMARK 500 SER A 751 70.30 -153.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1101 DISTANCE = 10.55 ANGSTROMS REMARK 525 HOH A1110 DISTANCE = 7.84 ANGSTROMS REMARK 525 HOH A1111 DISTANCE = 7.36 ANGSTROMS REMARK 525 HOH A1112 DISTANCE = 8.61 ANGSTROMS REMARK 525 HOH A1114 DISTANCE = 6.66 ANGSTROMS REMARK 525 HOH A1116 DISTANCE = 6.00 ANGSTROMS REMARK 525 HOH A1119 DISTANCE = 7.02 ANGSTROMS REMARK 525 HOH A1120 DISTANCE = 7.19 ANGSTROMS REMARK 525 HOH A1121 DISTANCE = 11.66 ANGSTROMS DBREF 3NC4 A 2 842 UNP P00489 PYGM_RABIT 3 843 SEQRES 1 A 841 ARG PRO LEU SER ASP GLN GLU LYS ARG LYS GLN ILE SER SEQRES 2 A 841 VAL ARG GLY LEU ALA GLY VAL GLU ASN VAL THR GLU LEU SEQRES 3 A 841 LYS LYS ASN PHE ASN ARG HIS LEU HIS PHE THR LEU VAL SEQRES 4 A 841 LYS ASP ARG ASN VAL ALA THR PRO ARG ASP TYR TYR PHE SEQRES 5 A 841 ALA LEU ALA HIS THR VAL ARG ASP HIS LEU VAL GLY ARG SEQRES 6 A 841 TRP ILE ARG THR GLN GLN HIS TYR TYR GLU LYS ASP PRO SEQRES 7 A 841 LYS ARG ILE TYR TYR LEU SER LEU GLU PHE TYR MET GLY SEQRES 8 A 841 ARG THR LEU GLN ASN THR MET VAL ASN LEU ALA LEU GLU SEQRES 9 A 841 ASN ALA CYS ASP GLU ALA THR TYR GLN LEU GLY LEU ASP SEQRES 10 A 841 MET GLU GLU LEU GLU GLU ILE GLU GLU ASP ALA GLY LEU SEQRES 11 A 841 GLY ASN GLY GLY LEU GLY ARG LEU ALA ALA CYS PHE LEU SEQRES 12 A 841 ASP SER MET ALA THR LEU GLY LEU ALA ALA TYR GLY TYR SEQRES 13 A 841 GLY ILE ARG TYR GLU PHE GLY ILE PHE ASN GLN LYS ILE SEQRES 14 A 841 CYS GLY GLY TRP GLN MET GLU GLU ALA ASP ASP TRP LEU SEQRES 15 A 841 ARG TYR GLY ASN PRO TRP GLU LYS ALA ARG PRO GLU PHE SEQRES 16 A 841 THR LEU PRO VAL HIS PHE TYR GLY ARG VAL GLU HIS THR SEQRES 17 A 841 SER GLN GLY ALA LYS TRP VAL ASP THR GLN VAL VAL LEU SEQRES 18 A 841 ALA MET PRO TYR ASP THR PRO VAL PRO GLY TYR ARG ASN SEQRES 19 A 841 ASN VAL VAL ASN THR MET ARG LEU TRP SER ALA LYS ALA SEQRES 20 A 841 PRO ASN ASP PHE ASN LEU LYS ASP PHE ASN VAL GLY GLY SEQRES 21 A 841 TYR ILE GLN ALA VAL LEU ASP ARG ASN LEU ALA GLU ASN SEQRES 22 A 841 ILE SER ARG VAL LEU TYR PRO ASN ASP ASN PHE PHE GLU SEQRES 23 A 841 GLY LYS GLU LEU ARG LEU LYS GLN GLU TYR PHE VAL VAL SEQRES 24 A 841 ALA ALA THR LEU GLN ASP ILE ILE ARG ARG PHE LYS SER SEQRES 25 A 841 SER LYS PHE GLY CYS ARG ASP PRO VAL ARG THR ASN PHE SEQRES 26 A 841 ASP ALA PHE PRO ASP LYS VAL ALA ILE GLN LEU ASN ASP SEQRES 27 A 841 THR HIS PRO SER LEU ALA ILE PRO GLU LEU MET ARG VAL SEQRES 28 A 841 LEU VAL ASP LEU GLU ARG LEU ASP TRP ASP LYS ALA TRP SEQRES 29 A 841 GLU VAL THR VAL LYS THR CYS ALA TYR THR ASN HIS THR SEQRES 30 A 841 VAL LEU PRO GLU ALA LEU GLU ARG TRP PRO VAL HIS LEU SEQRES 31 A 841 LEU GLU THR LEU LEU PRO ARG HIS LEU GLN ILE ILE TYR SEQRES 32 A 841 GLU ILE ASN GLN ARG PHE LEU ASN ARG VAL ALA ALA ALA SEQRES 33 A 841 PHE PRO GLY ASP VAL ASP ARG LEU ARG ARG MET SER LEU SEQRES 34 A 841 VAL GLU GLU GLY ALA VAL LYS ARG ILE ASN MET ALA HIS SEQRES 35 A 841 LEU CYS ILE ALA GLY SER HIS ALA VAL ASN GLY VAL ALA SEQRES 36 A 841 ARG ILE HIS SER GLU ILE LEU LYS LYS THR ILE PHE LYS SEQRES 37 A 841 ASP PHE TYR GLU LEU GLU PRO HIS LYS PHE GLN ASN LYS SEQRES 38 A 841 THR ASN GLY ILE THR PRO ARG ARG TRP LEU VAL LEU CYS SEQRES 39 A 841 ASN PRO GLY LEU ALA GLU ILE ILE ALA GLU ARG ILE GLY SEQRES 40 A 841 GLU GLU TYR ILE SER ASP LEU ASP GLN LEU ARG LYS LEU SEQRES 41 A 841 LEU SER TYR VAL ASP ASP GLU ALA PHE ILE ARG ASP VAL SEQRES 42 A 841 ALA LYS VAL LYS GLN GLU ASN LYS LEU LYS PHE ALA ALA SEQRES 43 A 841 TYR LEU GLU ARG GLU TYR LYS VAL HIS ILE ASN PRO ASN SEQRES 44 A 841 SER LEU PHE ASP VAL GLN VAL LYS ARG ILE HIS GLU TYR SEQRES 45 A 841 LYS ARG GLN LEU LEU ASN CYS LEU HIS VAL ILE THR LEU SEQRES 46 A 841 TYR ASN ARG ILE LYS LYS GLU PRO ASN LYS PHE VAL VAL SEQRES 47 A 841 PRO ARG THR VAL MET ILE GLY GLY LYS ALA ALA PRO GLY SEQRES 48 A 841 TYR HIS MET ALA LYS MET ILE ILE LYS LEU ILE THR ALA SEQRES 49 A 841 ILE GLY ASP VAL VAL ASN HIS ASP PRO VAL VAL GLY ASP SEQRES 50 A 841 ARG LEU ARG VAL ILE PHE LEU GLU ASN TYR ARG VAL SER SEQRES 51 A 841 LEU ALA GLU LYS VAL ILE PRO ALA ALA ASP LEU SER GLU SEQRES 52 A 841 GLN ILE SER THR ALA GLY THR GLU ALA SER GLY THR GLY SEQRES 53 A 841 ASN MET LLP PHE MET LEU ASN GLY ALA LEU THR ILE GLY SEQRES 54 A 841 THR MET ASP GLY ALA ASN VAL GLU MET ALA GLU GLU ALA SEQRES 55 A 841 GLY GLU GLU ASN PHE PHE ILE PHE GLY MET ARG VAL GLU SEQRES 56 A 841 ASP VAL ASP ARG LEU ASP GLN ARG GLY TYR ASN ALA GLN SEQRES 57 A 841 GLU TYR TYR ASP ARG ILE PRO GLU LEU ARG GLN ILE ILE SEQRES 58 A 841 GLU GLN LEU SER SER GLY PHE PHE SER PRO LYS GLN PRO SEQRES 59 A 841 ASP LEU PHE LYS ASP ILE VAL ASN MET LEU MET HIS HIS SEQRES 60 A 841 ASP ARG PHE LYS VAL PHE ALA ASP TYR GLU GLU TYR VAL SEQRES 61 A 841 LYS CYS GLN GLU ARG VAL SER ALA LEU TYR LYS ASN PRO SEQRES 62 A 841 ARG GLU TRP THR ARG MET VAL ILE ARG ASN ILE ALA THR SEQRES 63 A 841 SER GLY LYS PHE SER SER ASP ARG THR ILE ALA GLN TYR SEQRES 64 A 841 ALA ARG GLU ILE TRP GLY VAL GLU PRO SER ARG GLN ARG SEQRES 65 A 841 LEU PRO ALA PRO ASP GLU LYS ILE PRO MODRES 3NC4 LLP A 680 LYS HET LLP A 680 24 HET 26O A 998 24 HET 26O A 920 24 HETNAM LLP (2S)-2-AMINO-6-[[3-HYDROXY-2-METHYL-5- HETNAM 2 LLP (PHOSPHONOOXYMETHYL)PYRIDIN-4- HETNAM 3 LLP YL]METHYLIDENEAMINO]HEXANOIC ACID HETNAM 26O N-({(2E)-2-[(2-HYDROXYPHENYL) HETNAM 2 26O METHYLIDENE]HYDRAZINO}CARBONOTHIOYL)-BETA-D- HETNAM 3 26O GLUCOPYRANOSYLAMINE HETSYN LLP N'-PYRIDOXYL-LYSINE-5'-MONOPHOSPHATE HETSYN 26O 2-HYDROXYBENZALDEHYDE-4-(BETA-D-GLUCOPYRANOSYL) HETSYN 2 26O THIOSEMICARBAZONE; N-({(2E)-2-[(2-HYDROXYPHENYL) HETSYN 3 26O METHYLIDENE]HYDRAZINO}CARBONOTHIOYL)-BETA-D- HETSYN 4 26O GLUCOSYLAMINE; N-({(2E)-2-[(2-HYDROXYPHENYL) HETSYN 5 26O METHYLIDENE]HYDRAZINO}CARBONOTHIOYL)-D-GLUCOSYLAMINE; HETSYN 6 26O N-({(2E)-2-[(2-HYDROXYPHENYL) HETSYN 7 26O METHYLIDENE]HYDRAZINO}CARBONOTHIOYL)-GLUCOSYLAMINE FORMUL 1 LLP C14 H22 N3 O7 P FORMUL 2 26O 2(C14 H19 N3 O6 S) FORMUL 4 HOH *282(H2 O) HELIX 1 1 ILE A 13 GLY A 17 5 5 HELIX 2 2 GLY A 20 THR A 38 1 19 HELIX 3 3 THR A 47 HIS A 62 1 16 HELIX 4 4 LEU A 63 ASP A 78 1 16 HELIX 5 5 THR A 94 LEU A 102 1 9 HELIX 6 6 LEU A 104 LEU A 115 1 12 HELIX 7 7 ASP A 118 GLU A 124 1 7 HELIX 8 8 GLY A 134 LEU A 150 1 17 HELIX 9 9 PRO A 194 THR A 197 5 4 HELIX 10 10 GLY A 261 ASP A 268 1 8 HELIX 11 11 ASP A 268 ASN A 274 1 7 HELIX 12 12 ILE A 275 ARG A 277 5 3 HELIX 13 13 LYS A 289 SER A 313 1 25 HELIX 14 14 ASN A 325 ASP A 327 5 3 HELIX 15 15 ALA A 328 LYS A 332 1 5 HELIX 16 16 LEU A 344 LEU A 356 1 13 HELIX 17 17 ASP A 360 THR A 371 1 12 HELIX 18 18 LEU A 380 LEU A 384 5 5 HELIX 19 19 VAL A 389 LEU A 396 1 8 HELIX 20 20 LEU A 396 PHE A 418 1 23 HELIX 21 21 ASP A 421 SER A 429 1 9 HELIX 22 22 MET A 441 GLY A 448 1 8 HELIX 23 23 ALA A 456 THR A 466 1 11 HELIX 24 24 PHE A 468 GLU A 475 1 8 HELIX 25 25 THR A 487 LEU A 492 1 6 HELIX 26 26 ASN A 496 GLY A 508 1 13 HELIX 27 27 GLU A 509 VAL A 525 5 17 HELIX 28 28 ASP A 527 LYS A 554 1 28 HELIX 29 29 HIS A 571 LYS A 574 5 4 HELIX 30 30 ARG A 575 GLU A 593 1 19 HELIX 31 31 TYR A 613 ASN A 631 1 19 HELIX 32 32 VAL A 636 ASP A 638 5 3 HELIX 33 33 ARG A 649 ILE A 657 1 9 HELIX 34 34 PRO A 658 ALA A 660 5 3 HELIX 35 35 THR A 676 ASN A 684 1 9 HELIX 36 36 ALA A 695 GLY A 704 1 10 HELIX 37 37 GLU A 705 PHE A 708 5 4 HELIX 38 38 ARG A 714 GLY A 725 1 12 HELIX 39 39 ASN A 727 ILE A 735 1 9 HELIX 40 40 ILE A 735 GLY A 748 1 14 HELIX 41 41 PHE A 758 HIS A 768 1 11 HELIX 42 42 VAL A 773 ALA A 775 5 3 HELIX 43 43 ASP A 776 LYS A 792 1 17 HELIX 44 44 ASN A 793 THR A 807 1 15 HELIX 45 45 SER A 808 PHE A 811 5 4 HELIX 46 46 SER A 812 ILE A 824 1 13 SHEET 1 A 3 LYS A 191 ALA A 192 0 SHEET 2 A 3 GLN A 219 PRO A 231 -1 O ASP A 227 N LYS A 191 SHEET 3 A 3 LEU A 198 PHE A 202 -1 N PHE A 202 O GLN A 219 SHEET 1 B 9 LYS A 191 ALA A 192 0 SHEET 2 B 9 GLN A 219 PRO A 231 -1 O ASP A 227 N LYS A 191 SHEET 3 B 9 VAL A 238 LYS A 247 -1 O SER A 245 N MET A 224 SHEET 4 B 9 ALA A 154 ILE A 159 1 N GLY A 156 O ARG A 242 SHEET 5 B 9 ARG A 81 LEU A 85 1 N TYR A 84 O TYR A 155 SHEET 6 B 9 VAL A 333 ASN A 338 1 O ALA A 334 N TYR A 83 SHEET 7 B 9 CYS A 372 THR A 375 1 O ALA A 373 N LEU A 337 SHEET 8 B 9 ALA A 451 GLY A 454 1 O ALA A 451 N TYR A 374 SHEET 9 B 9 PHE A 479 ASN A 481 1 O GLN A 480 N VAL A 452 SHEET 1 C 2 PHE A 89 GLY A 92 0 SHEET 2 C 2 ALA A 129 LEU A 131 -1 O ALA A 129 N GLY A 92 SHEET 1 D 2 ASN A 167 CYS A 171 0 SHEET 2 D 2 TRP A 174 GLU A 178 -1 O TRP A 174 N CYS A 171 SHEET 1 E 2 ARG A 205 THR A 209 0 SHEET 2 E 2 GLY A 212 VAL A 216 -1 O LYS A 214 N GLU A 207 SHEET 1 F 3 ARG A 386 PRO A 388 0 SHEET 2 F 3 ARG A 438 ASN A 440 -1 O ILE A 439 N TRP A 387 SHEET 3 F 3 VAL A 431 GLU A 432 -1 N GLU A 432 O ARG A 438 SHEET 1 G 6 LEU A 640 LEU A 645 0 SHEET 2 G 6 ARG A 601 GLY A 606 1 N VAL A 603 O ARG A 641 SHEET 3 G 6 LEU A 562 VAL A 567 1 N ASP A 564 O MET A 604 SHEET 4 G 6 LEU A 662 GLN A 665 1 O LEU A 662 N PHE A 563 SHEET 5 G 6 LEU A 687 GLY A 690 1 O LEU A 687 N SER A 663 SHEET 6 G 6 PHE A 709 ILE A 710 1 O PHE A 709 N THR A 688 LINK C MET A 679 N LLP A 680 1555 1555 1.34 LINK C LLP A 680 N PHE A 681 1555 1555 1.34 CRYST1 128.517 128.517 115.843 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007781 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007781 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008632 0.00000